Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
40 participants
INTERVENTIONAL
2009-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MYSTAR-5-YEAR: Long-term Follow-up of Patients With Ischemic Heart Disease Treated With Cell Therapy
NCT01395212
Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration
NCT00938847
Effects of Intracoronary Progenitor Cell Therapy on Coronary Flow Reserve After Acute MI
NCT00711542
Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI
NCT02323620
Efficacy Study of Intramuscular or Intracoronary Injection of Autologous Bone Marrow Cells to Treat Scarred Myocardium
NCT00560742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
PCI plus BNNC Therapy after acute myocardial infarction
BMNC therapy
Injection of BMNC after common PCI
2
Percutaneous Coronary Intervention after acute myocardial infarction
Percutaneous Coronary Intervention
common Percutaneous Coronary Intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous Coronary Intervention
common Percutaneous Coronary Intervention
BMNC therapy
Injection of BMNC after common PCI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* conventional therapy according to the ESC guidelines for heart failure
* BMI \> 20 and \< 35
Exclusion Criteria
* relevant valvular disease
* history of stroke/multivessel disease/thromboembolic event etc.
* DM Type I
* pregancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asklepios proresearch
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karl-Heinz Kuck, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Asklepios Klinik St. Georg, Department of Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asklepios Klinik St. Georg
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-004625-42
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
1777
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.